FIBROBLAST GROWTH FACTOR (FGF-2) PREVENTS HUMAN CARDIAC FIBROBLAST-MEDIATED EXTRACELLULAR MATRIX REMODELING

Authors :: Holly E.M. Mewhort
Paul W.M. Fedak
Darrell D. Belke
Janet M.C. Ngu
David G. Guzzardi
Guoqi Teng
B.D. Lipon
D.A. Svystonyuk
D. Park
Source :: Canadian Journal of Cardiology. 30:S153
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.
Abstract: s S153 CONCLUSION: In this pilot study there were no observable histological differences in human right atrial tissue from individuals at highand low-risk for OSA. Further investigation would be required for more definitive results. Canadian Cardiovascular Society (CCS) Oral

Subjects :: Extracellular matrix
Cardiac fibroblast
business.industry
Cancer research
Medicine
Canadian Cardiovascular Society
Cardiology and Cardiovascular Medicine
Fibroblast growth factor
business
Right atrial

Full Text Access

Tools